Baidu
map

诸暨辟谣发现5例确诊病例:1为无症状感染者,4人尚在甄别

2020-04-05 佚名 “诸暨发布”微信公号

“诸暨发布”微信公号4月5日消息,近期,我市陆续出现“诸暨发现5例新冠肺炎确诊病例”等流言传闻。

“诸暨发布”微信公号4月5日消息,近期,我市陆续出现“诸暨发现5例新冠肺炎确诊病例”等流言传闻。

经调查,以上5人中,4人来自境外,1人来自疫情重点地区。上述5人进入诸暨后一直处于隔离状态,未与外界接触。经诸暨、绍兴检测甄别,1人被确认为无症状感染病例,4月4日已公开发布,其余4人目前尚处于上级部门检测甄别阶段。一旦确诊,有关部门会按相关防控要求做好处置工作。同时,按照信息发布规定,第一时间通过诸暨发布、官方媒体向社会公布相关信息。

针对各种不实信息,我市公安机关已经开展侦查工作,对散布不实消息,泄露公民个人隐私的,一经查实,将依法依规严肃处理。希望广大市民做到不造谣、不信谣、不传谣,共同打赢疫情防控攻坚战。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1679592, encodeId=ace316e959227, content=<a href='/topic/show?id=7c549386054' target=_blank style='color:#2F92EE;'>#辟谣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93860, encryptionId=7c549386054, topicName=辟谣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf127794231, createdName=feather87, createdTime=Sat May 16 18:26:48 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353269, encodeId=ceec1353269d0, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Apr 07 07:26:48 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485087, encodeId=9afc148508edc, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Apr 07 07:26:48 CST 2020, time=2020-04-07, status=1, ipAttribution=)]
    2020-05-16 feather87
  2. [GetPortalCommentsPageByObjectIdResponse(id=1679592, encodeId=ace316e959227, content=<a href='/topic/show?id=7c549386054' target=_blank style='color:#2F92EE;'>#辟谣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93860, encryptionId=7c549386054, topicName=辟谣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf127794231, createdName=feather87, createdTime=Sat May 16 18:26:48 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353269, encodeId=ceec1353269d0, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Apr 07 07:26:48 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485087, encodeId=9afc148508edc, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Apr 07 07:26:48 CST 2020, time=2020-04-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1679592, encodeId=ace316e959227, content=<a href='/topic/show?id=7c549386054' target=_blank style='color:#2F92EE;'>#辟谣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93860, encryptionId=7c549386054, topicName=辟谣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf127794231, createdName=feather87, createdTime=Sat May 16 18:26:48 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353269, encodeId=ceec1353269d0, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Apr 07 07:26:48 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485087, encodeId=9afc148508edc, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Apr 07 07:26:48 CST 2020, time=2020-04-07, status=1, ipAttribution=)]
Baidu
map
Baidu
map
Baidu
map